Is the clinical benefit of implantable cardioverter-defibrillators in heart failure patients declining?
•The clinical effectiveness of ICD therapy in non-ischemic patients is under debate.•A more reliable risk stratification tool is urgently required.•Further studies are required to elucidate the efficacy of ICD therapy.
Gespeichert in:
| Veröffentlicht in: | Journal of cardiology 2020-05, Vol.75 (5), p.583-584 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 584 |
|---|---|
| container_issue | 5 |
| container_start_page | 583 |
| container_title | Journal of cardiology |
| container_volume | 75 |
| creator | Spartalis, Michael Iliopoulos, Dimitrios C. Spartalis, Eleftherios Athanasiou, Antonios Paschou, Stavroula A. Voudris, Vassilis Siasos, Gerasimos |
| description | •The clinical effectiveness of ICD therapy in non-ischemic patients is under debate.•A more reliable risk stratification tool is urgently required.•Further studies are required to elucidate the efficacy of ICD therapy. |
| doi_str_mv | 10.1016/j.jjcc.2020.02.002 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2369875790</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0914508720300459</els_id><sourcerecordid>2369875790</sourcerecordid><originalsourceid>FETCH-LOGICAL-c424t-9356791a0bf20152252c8ef46c9386485012c32ce5b351c18b154f7e7b4150303</originalsourceid><addsrcrecordid>eNp9kD1PwzAQhi0EoqXwBxiQR5aEsx0njoSEUMVHpUosMFuOcymO0qTYbiX-PSkFRqYb7nlf3T2EXDJIGbD8pk3b1tqUA4cUeArAj8iUqSJPskKoYzKFkmWJBFVMyFkILUAOpcpPyURwxqTg5ZSsFoHGd6S2c72zpqMV9ti4SIeGuvWmM300VTfuja_dsEMf0Sf1SFTedZ2Jgw_U9fQdjY-0Ma7beqQbEx32MdAav3v71d05OWlMF_DiZ87I2-PD6_w5Wb48Leb3y8RmPItJKWRelMxA1XBgknPJrcImy20pVJ4pCYxbwS3KSkhmmaqYzJoCiypjEgSIGbk-9G788LHFEPXaBYvjqT0O26C5yEtVyKLco_yAWj-E4LHRG-_Wxn9qBnovWLd6L1jvBWvgehQ8hq5--rfVGuu_yK_REbg9ADh-uXPodbCjDIu182ijrgf3X_8XFC2MCA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2369875790</pqid></control><display><type>article</type><title>Is the clinical benefit of implantable cardioverter-defibrillators in heart failure patients declining?</title><source>MEDLINE</source><source>ScienceDirect Freedom Collection (Elsevier)</source><source>Free E-Journal (出版社公開部分のみ）</source><creator>Spartalis, Michael ; Iliopoulos, Dimitrios C. ; Spartalis, Eleftherios ; Athanasiou, Antonios ; Paschou, Stavroula A. ; Voudris, Vassilis ; Siasos, Gerasimos</creator><creatorcontrib>Spartalis, Michael ; Iliopoulos, Dimitrios C. ; Spartalis, Eleftherios ; Athanasiou, Antonios ; Paschou, Stavroula A. ; Voudris, Vassilis ; Siasos, Gerasimos</creatorcontrib><description>•The clinical effectiveness of ICD therapy in non-ischemic patients is under debate.•A more reliable risk stratification tool is urgently required.•Further studies are required to elucidate the efficacy of ICD therapy.</description><identifier>ISSN: 0914-5087</identifier><identifier>EISSN: 1876-4738</identifier><identifier>DOI: 10.1016/j.jjcc.2020.02.002</identifier><identifier>PMID: 32115329</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Death, Sudden, Cardiac - epidemiology ; Death, Sudden, Cardiac - etiology ; Death, Sudden, Cardiac - prevention & control ; Defibrillator ; Defibrillators, Implantable ; Heart failure ; Heart Failure - therapy ; Humans ; ICD ; Primary prevention ; Randomized Controlled Trials as Topic ; Sudden cardiac death</subject><ispartof>Journal of cardiology, 2020-05, Vol.75 (5), p.583-584</ispartof><rights>2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c424t-9356791a0bf20152252c8ef46c9386485012c32ce5b351c18b154f7e7b4150303</citedby><cites>FETCH-LOGICAL-c424t-9356791a0bf20152252c8ef46c9386485012c32ce5b351c18b154f7e7b4150303</cites><orcidid>0000-0002-7442-838X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jjcc.2020.02.002$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32115329$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Spartalis, Michael</creatorcontrib><creatorcontrib>Iliopoulos, Dimitrios C.</creatorcontrib><creatorcontrib>Spartalis, Eleftherios</creatorcontrib><creatorcontrib>Athanasiou, Antonios</creatorcontrib><creatorcontrib>Paschou, Stavroula A.</creatorcontrib><creatorcontrib>Voudris, Vassilis</creatorcontrib><creatorcontrib>Siasos, Gerasimos</creatorcontrib><title>Is the clinical benefit of implantable cardioverter-defibrillators in heart failure patients declining?</title><title>Journal of cardiology</title><addtitle>J Cardiol</addtitle><description>•The clinical effectiveness of ICD therapy in non-ischemic patients is under debate.•A more reliable risk stratification tool is urgently required.•Further studies are required to elucidate the efficacy of ICD therapy.</description><subject>Death, Sudden, Cardiac - epidemiology</subject><subject>Death, Sudden, Cardiac - etiology</subject><subject>Death, Sudden, Cardiac - prevention & control</subject><subject>Defibrillator</subject><subject>Defibrillators, Implantable</subject><subject>Heart failure</subject><subject>Heart Failure - therapy</subject><subject>Humans</subject><subject>ICD</subject><subject>Primary prevention</subject><subject>Randomized Controlled Trials as Topic</subject><subject>Sudden cardiac death</subject><issn>0914-5087</issn><issn>1876-4738</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kD1PwzAQhi0EoqXwBxiQR5aEsx0njoSEUMVHpUosMFuOcymO0qTYbiX-PSkFRqYb7nlf3T2EXDJIGbD8pk3b1tqUA4cUeArAj8iUqSJPskKoYzKFkmWJBFVMyFkILUAOpcpPyURwxqTg5ZSsFoHGd6S2c72zpqMV9ti4SIeGuvWmM300VTfuja_dsEMf0Sf1SFTedZ2Jgw_U9fQdjY-0Ma7beqQbEx32MdAav3v71d05OWlMF_DiZ87I2-PD6_w5Wb48Leb3y8RmPItJKWRelMxA1XBgknPJrcImy20pVJ4pCYxbwS3KSkhmmaqYzJoCiypjEgSIGbk-9G788LHFEPXaBYvjqT0O26C5yEtVyKLco_yAWj-E4LHRG-_Wxn9qBnovWLd6L1jvBWvgehQ8hq5--rfVGuu_yK_REbg9ADh-uXPodbCjDIu182ijrgf3X_8XFC2MCA</recordid><startdate>20200501</startdate><enddate>20200501</enddate><creator>Spartalis, Michael</creator><creator>Iliopoulos, Dimitrios C.</creator><creator>Spartalis, Eleftherios</creator><creator>Athanasiou, Antonios</creator><creator>Paschou, Stavroula A.</creator><creator>Voudris, Vassilis</creator><creator>Siasos, Gerasimos</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7442-838X</orcidid></search><sort><creationdate>20200501</creationdate><title>Is the clinical benefit of implantable cardioverter-defibrillators in heart failure patients declining?</title><author>Spartalis, Michael ; Iliopoulos, Dimitrios C. ; Spartalis, Eleftherios ; Athanasiou, Antonios ; Paschou, Stavroula A. ; Voudris, Vassilis ; Siasos, Gerasimos</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c424t-9356791a0bf20152252c8ef46c9386485012c32ce5b351c18b154f7e7b4150303</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Death, Sudden, Cardiac - epidemiology</topic><topic>Death, Sudden, Cardiac - etiology</topic><topic>Death, Sudden, Cardiac - prevention & control</topic><topic>Defibrillator</topic><topic>Defibrillators, Implantable</topic><topic>Heart failure</topic><topic>Heart Failure - therapy</topic><topic>Humans</topic><topic>ICD</topic><topic>Primary prevention</topic><topic>Randomized Controlled Trials as Topic</topic><topic>Sudden cardiac death</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Spartalis, Michael</creatorcontrib><creatorcontrib>Iliopoulos, Dimitrios C.</creatorcontrib><creatorcontrib>Spartalis, Eleftherios</creatorcontrib><creatorcontrib>Athanasiou, Antonios</creatorcontrib><creatorcontrib>Paschou, Stavroula A.</creatorcontrib><creatorcontrib>Voudris, Vassilis</creatorcontrib><creatorcontrib>Siasos, Gerasimos</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Spartalis, Michael</au><au>Iliopoulos, Dimitrios C.</au><au>Spartalis, Eleftherios</au><au>Athanasiou, Antonios</au><au>Paschou, Stavroula A.</au><au>Voudris, Vassilis</au><au>Siasos, Gerasimos</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Is the clinical benefit of implantable cardioverter-defibrillators in heart failure patients declining?</atitle><jtitle>Journal of cardiology</jtitle><addtitle>J Cardiol</addtitle><date>2020-05-01</date><risdate>2020</risdate><volume>75</volume><issue>5</issue><spage>583</spage><epage>584</epage><pages>583-584</pages><issn>0914-5087</issn><eissn>1876-4738</eissn><abstract>•The clinical effectiveness of ICD therapy in non-ischemic patients is under debate.•A more reliable risk stratification tool is urgently required.•Further studies are required to elucidate the efficacy of ICD therapy.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>32115329</pmid><doi>10.1016/j.jjcc.2020.02.002</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0002-7442-838X</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0914-5087 |
| ispartof | Journal of cardiology, 2020-05, Vol.75 (5), p.583-584 |
| issn | 0914-5087 1876-4738 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2369875790 |
| source | MEDLINE; ScienceDirect Freedom Collection (Elsevier); Free E-Journal (出版社公開部分のみ） |
| subjects | Death, Sudden, Cardiac - epidemiology Death, Sudden, Cardiac - etiology Death, Sudden, Cardiac - prevention & control Defibrillator Defibrillators, Implantable Heart failure Heart Failure - therapy Humans ICD Primary prevention Randomized Controlled Trials as Topic Sudden cardiac death |
| title | Is the clinical benefit of implantable cardioverter-defibrillators in heart failure patients declining? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T09%3A21%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Is%20the%20clinical%20benefit%20of%20implantable%20cardioverter-defibrillators%20in%20heart%20failure%20patients%20declining?&rft.jtitle=Journal%20of%20cardiology&rft.au=Spartalis,%20Michael&rft.date=2020-05-01&rft.volume=75&rft.issue=5&rft.spage=583&rft.epage=584&rft.pages=583-584&rft.issn=0914-5087&rft.eissn=1876-4738&rft_id=info:doi/10.1016/j.jjcc.2020.02.002&rft_dat=%3Cproquest_cross%3E2369875790%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2369875790&rft_id=info:pmid/32115329&rft_els_id=S0914508720300459&rfr_iscdi=true |